{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:17:11Z","timestamp":1783487831670,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.neurol.2015.02.016","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T19:21:55Z","timestamp":1432149715000},"page":"572-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Guidelines for presymptomatic testing for Huntington's disease: Past, present and future in France"],"prefix":"10.1016","volume":"171","author":[{"given":"S.","family":"Cl\u00e9ment","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2015.02.016_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2015.02.016_bib0010","series-title":"Huntington's disease. Oxford monographs on medical genetics","first-page":"3","article-title":"Huntington's disease in a historical context","author":"Harper","year":"2014"},{"issue":"5940","key":"10.1016\/j.neurol.2015.02.016_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","article-title":"A polymorphic DNA marker genetically linked to Huntington's disease","volume":"306","author":"Gusella","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2015.02.016_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ajmg.1320280329","article-title":"Letter to the editor: Ethical issues in preclinical testing in Huntington's disease: response to Margery Shaw's invited editorial comment","volume":"28","author":"Hayden","year":"1987","journal-title":"Am J Med Genet"},{"issue":"1\u20133","key":"10.1016\/j.neurol.2015.02.016_bib0025","first-page":"327","article-title":"Ethical issues policy statement on Huntington's disease molecular genetics predictive test","volume":"94","author":"World Federation of Neurology: Research Committee","year":"1989","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.neurol.2015.02.016_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmg.27.1.34","article-title":"Ethical issues policy statement on Huntington's disease molecular genetics predictive test","volume":"27","author":"Went","year":"1990","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2015.02.016_bib0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jmg.31.7.555","article-title":"Guidelines for the molecular genetics predictive test in Huntington's disease","volume":"31","author":"International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurol.2015.02.016_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ejhg.2008.146","article-title":"Long-term outcome of presymptomatic testing in Huntington's disease","volume":"17","author":"Gargiulo","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.neurol.2015.02.016_bib0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1051\/medsci\/20052111934","article-title":"Predictive testing: presymptomatic diagnosis in neurogenetic disorders","volume":"21","author":"D\u00fcrr","year":"2005","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.neurol.2015.02.016_bib0050","series-title":"Care and the clinical approach of uncertainty","first-page":"171","article-title":"L\u2019\u00e9loge de l\u2019incertitude en consultation g\u00e9n\u00e9tique. Du soin \u00e0 la personne, clinique de l\u2019incertitude{{nl}}Praise of uncertainty within the genetic consulation","author":"Gargiulo","year":"2013"},{"issue":"9246","key":"10.1016\/j.neurol.2015.02.016_bib0055","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/S0140-6736(00)03301-8","article-title":"Predictive testing for Huntington's disease: the calm after the storm","volume":"356","author":"Hayden","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neurol.2015.02.016_bib0060","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/01.WNL.0000032255.75650.C2","article-title":"Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias","volume":"59","author":"Goizet","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2015.02.016_bib0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ejhg.2008.142","article-title":"Problems assessing uptake of Huntington disease predictive testing and a proposed solution","volume":"17","author":"Tassicker","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.neurol.2015.02.016_bib0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","article-title":"Uptake of Huntington disease predictive testing in a complete population","volume":"80","author":"Morrison","year":"2011","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.neurol.2015.02.016_bib0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ejhg.2012.147","article-title":"When access is an issue: exploring barriers to predictive testing for Huntington's disease in British Columbia, Canada","volume":"21","author":"Hawkins","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2015.02.016_bib0080","series-title":"\u00c9tude sur le devenir apr\u00e8s un test pr\u00e9symptomatique de la maladie de Huntington","author":"Evrard","year":"2001"},{"issue":"7","key":"10.1016\/j.neurol.2015.02.016_bib0085","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jmg.39.7.522","article-title":"Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia","volume":"39","author":"Lesca","year":"2002","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.neurol.2015.02.016_bib0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ejhg.2011.202","article-title":"Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres","volume":"20","author":"Van Rij","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.neurol.2015.02.016_bib0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/humupd\/dms058","article-title":"Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections","volume":"19","author":"de Die-Smulders","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.neurol.2015.02.016_bib0100","series-title":"Huntington's disease. Oxford monographs on medical genetics","first-page":"165","article-title":"Genetic counselling and testing","author":"Macleod","year":"2014"},{"key":"10.1016\/j.neurol.2015.02.016_bib0105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/302374","article-title":"A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington's disease","volume":"64","author":"Almqvist","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurol.2015.02.016_bib0110","series-title":"Premi\u00e8res assises de g\u00e9n\u00e9tique humaine et m\u00e9dicale, Marseille","article-title":"Maladie dominante \u00e0 r\u00e9v\u00e9lation tardive\u00a0: l\u2019information du risque dans les familles","author":"Gargiulo","year":"2002"},{"issue":"2","key":"10.1016\/j.neurol.2015.02.016_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neurol.2007.08.002","article-title":"\u00c0 propos de la maladie de Huntington\u00a0: r\u00f4les respectifs de la famille et des professionnels de sant\u00e9 dans la transmission de l\u2019information","volume":"164","author":"Delliaux","year":"2008","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2015.02.016_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","article-title":"Recommendations for the predictive genetic test in Huntington's disease","volume":"83","author":"Macleod","year":"2012","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2015.02.016_bib0125","unstructured":"Loi no\u00a094-654\u00a0du 29\u00a0juillet 1994\u00a0relative au don et \u00e0 l\u2019utilisation des \u00e9l\u00e9ments et produits du corps humain, \u00e0 l\u2019assistance m\u00e9dicale \u00e0 la procr\u00e9ation et au diagnostic pr\u00e9natal."},{"key":"10.1016\/j.neurol.2015.02.016_bib0130","series-title":"Les tests g\u00e9n\u00e9tiques \u2013\u00a0Contributions \u00e0 une \u00e9tude juridique","author":"Supiot","year":"2012"},{"key":"10.1016\/j.neurol.2015.02.016_bib0135","unstructured":"D\u00e9cret no\u00a02000-570\u00a0du 23\u00a0juin 2000\u00a0fixant les conditions de prescription et de r\u00e9alisation des examens des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne et de son identification par empreintes g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales et modifiant le code de la sant\u00e9 publique (deuxi\u00e8me partie\u00a0: d\u00e9crets en Conseil d\u2019\u00c9tat)."},{"key":"10.1016\/j.neurol.2015.02.016_bib0140","unstructured":"Loi no\u00a02004-800\u00a0du 6\u00a0ao\u00fbt 2004\u00a0relative \u00e0 la bio\u00e9thique."},{"key":"10.1016\/j.neurol.2015.02.016_bib0145","unstructured":"Loi no\u00a02011-814\u00a0du 7\u00a0juillet 2011\u00a0relative \u00e0 la bio\u00e9thique (1)."},{"key":"10.1016\/j.neurol.2015.02.016_bib0150","unstructured":"D\u00e9cret no\u00a02013-527\u00a0du 20\u00a0juin 2013\u00a0relatif aux conditions de mise en \u0153uvre de l\u2019information de la parent\u00e8le dans le cadre d\u2019un examen des caract\u00e9ristiques g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales."},{"key":"10.1016\/j.neurol.2015.02.016_bib0155","unstructured":"Arr\u00eat\u00e9 du 27\u00a0mai 2013\u00a0d\u00e9finissant les r\u00e8gles de bonnes pratiques applicables \u00e0 l\u2019examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne \u00e0 des fins m\u00e9dicales."},{"key":"10.1016\/j.neurol.2015.02.016_bib0160","unstructured":"Arr\u00eat\u00e9 du 20\u00a0juin 2013\u00a0fixant le mod\u00e8le de lettre adress\u00e9e par le m\u00e9decin aux membres de la famille potentiellement concern\u00e9s en application de l\u2019article R.\u00a01131-20-2\u00a0du Code de la sant\u00e9 publique."},{"issue":"7","key":"10.1016\/j.neurol.2015.02.016_bib0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2015.02.016_bib0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neurol.2012.07.003","article-title":"The presymptomatic phase of Huntington disease","volume":"168","author":"Durr","year":"2012","journal-title":"Rev Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715007390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715007390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:24:32Z","timestamp":1537622672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378715007390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":34,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0035378715007390"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2015.02.016","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for presymptomatic testing for Huntington's disease: Past, present and future in France","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2015.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}